Skip to Main Content

Author Details

Matthew W McCarthy
Weill Cornell Medical College, New York-Presbyterian Hospital
2014
81
18
PMIDPaper TitleJournal TitlePublished Year
36927284Montelukast as a potential treatment for COVID-19.Expert Opin Pharmacother2023
37731377Paxlovid as a potential treatment for long COVID.Expert Opin Pharmacother2023
37191706Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.JAMA2023
37421632Optimizing the use of vilobelimab for the treatment of COVID-19.Expert Opin Biol Ther2023
37147857Interferon lambda as a potential treatment for COVID-19.Expert Opin Biol Ther2023
37194484Metformin as a potential treatment for COVID-19.Expert Opin Pharmacother2023
36847621Anakinra as a potential treatment for COVID-19.Drugs Today (Barc)2023
36932818VV116 as a potential treatment for COVID-19.Expert Opin Pharmacother2023
36633838Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA2023
36413380Infliximab as a potential treatment for COVID-19.Expert Rev Anti Infect Ther2023
34797183Ethical challenges of prospective clinical trials during the COVID-19 pandemic.Expert Rev Anti Infect Ther2022
35549623Outpatient treatment options to address the SARS-CoV-2 variant Omicron.Expert Rev Anti Infect Ther2022
35535815Fluticasone propionate as a potential treatment for COVID-19.Drugs Today (Barc)2022
36448782Osteoarticular Mycoses.Clin Microbiol Rev2022
36686626Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms.Open Forum Infect Dis2022
36422515Optimizing the use of Paxlovid in clinical practice.Drugs Today (Barc)2022
35999352Novel Strategies for the Treatment of COVID-19.Drugs R D2022
36243027Original antigen sin and COVID-19: implications for seasonal vaccination.Expert Opin Biol Ther2022
35997157Recent advances in the diagnosis monkeypox: implications for public health.Expert Rev Mol Diagn2022
36271630Treatment of severe COVID-19: an evolving paradigm.Expert Opin Pharmacother2022
36269852Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA2022
35953443Therapeutic strategies to address monkeypox.Expert Rev Anti Infect Ther2022
36350029Ensitrelvir as a potential treatment for COVID-19.Expert Opin Pharmacother2022
34997392The Diagnostic Accuracy Of Procalcitonin for Urinary Tract Infection in Hospitalized Older Adults: a Prospective Study.J Gen Intern Med2022
35175568Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections.Drugs R D2022
34961907Pharmacokinetics and Pharmacodynamics of Ibrexafungerp.Drugs R D2022
35103549Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19).Expert Opin Pharmacother2022
33403877At-home coronavirus testing: the next game-changer?Expert Rev Mol Diagn2021
34274058The Great Gatsby and the challenge of unreliable narrators.Lancet2021
34254252Clinical Pharmacokinetics and Pharmacodynamics of Lefamulin.Clin Pharmacokinet2021
32482961Efficacy of Amphotericin B in Corneal Preservation Media After Extended Frozen Storage.Cornea2020
31667954Procalcitonin utilization in the real world: An observational study of antibiotic prescribing practices.J Eval Clin Pract2020
31713130Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial.Infect Dis Ther2020
32009210Clinical Pharmacokinetics and Pharmacodynamics of Imipenem-Cilastatin/Relebactam Combination Therapy.Clin Pharmacokinet2020
32366131Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine.Expert Rev Anti Infect Ther2020
32282864Cefiderocol to treat complicated urinary tract infection.Drugs Today (Barc)2020
30449226Teixobactin: a novel anti-infective agent.Expert Rev Anti Infect Ther2019
31433773Clinical Progress Note: Procalcitonin in the Diagnosis and Management of Community-Acquired Pneumonia in Hospitalized Adults.J Hosp Med2019
30897052Frequency of Ethical Issues on a Hospitalist Teaching Service at an Urban, Tertiary Care Center.J Hosp Med2019
31049869Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline.Clin Pharmacokinet2019
30682890The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases.Expert Rev Mol Diagn2019
29318906Cefiderocol: a novel siderophore cephalosporin.Expert Opin Investig Drugs2018
29805152Off the Charts: <i>Medical documentation and selective redaction in the age of transparency</i>.Perspect Biol Med2018
29912161Recent Advances in the Treatment of Scedosporiosis and Fusariosis.J Fungi (Basel)2018
29897826Galactomannan antigenemia as a biomarker for therapeutic response of invasive aspergillosis: implications for clinical trial design and patient care.Expert Rev Mol Diagn2018
30322269Candidemia in the cancer patient: diagnosis, treatment, and future directions.Expert Rev Anti Infect Ther2018
30412683The surviving sepsis controversy: a call to action for hospital medicine.Expert Rev Anti Infect Ther2018
30303492Plazomicin for the treatment of patients with complicated urinary tract infection.Drugs Today (Barc)2018
29725999Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.Clin Pharmacokinet2018
29562716Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets.Int J Mol Sci2018
  • 1 - 50 of 81

Recommended Authors

University of Chicago
Career Start Year 2015
Number of shared co-authors 3
McGill University
Career Start Year 2014
Number of shared co-authors 0
Department of Pharmacy, Beth Israel Deaconess Medical Center
Career Start Year 2013
Number of shared co-authors 0
Kent County Hospital
Career Start Year 2013
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 3
Rochester General Hospital
Career Start Year 2011
Number of shared co-authors 4
Massachusetts General Hospital
Career Start Year 2011
Number of shared co-authors 0
Mayo Foundation for Medical Education and Research
Career Start Year 2009
Number of shared co-authors 0
Children's Hospital of Philadelphia
Career Start Year 2009
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Boston University
Career Start Year 2007
Number of shared co-authors 0
University of Kansas Medical Center
Career Start Year 2006
Number of shared co-authors 4
Trinity Health St Joseph Mercy Hospital
Career Start Year 2005
Number of shared co-authors 3
University of California, Davis Center for Valley Fever
Career Start Year 2005
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Children's Mercy Hospitals and Clinics
Career Start Year 2004
Number of shared co-authors 0
University of Toronto, University Avenue
Career Start Year 2003
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2003
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of Nebraska School of Medicine
Career Start Year 2002
Number of shared co-authors 1
NanoString Technologies Inc.
Career Start Year 2002
Number of shared co-authors 0
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Career Start Year 1999
Number of shared co-authors 0
Federal University of Rio de Janeiro
Career Start Year 1998
Number of shared co-authors 3
Waterbury Hospital
Career Start Year 1998
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 1
VA Medical Center
Career Start Year 1986
Number of shared co-authors 3
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Career Start Year 1986
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Division of Medical Ethics, Weill Cornell Medical College
Co-authored papers 6
NIH Clinical Center
Co-authored papers 3
Duke Clinical Research Institute and Duke University School of Medicine
Co-authored papers 3
Duke University
Co-authored papers 3
University of Pittsburgh
Co-authored papers 2
Duke University School of Medicine
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
University of Florida
Co-authored papers 2
Duke Clinical Research Institute, Duke University
Co-authored papers 2
Lewis Katz School of Medicine at Temple University
Co-authored papers 2
Duke University Medical Center
Co-authored papers 2
University of Miami, Miller School of Medicine
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
University of Minnesota
Co-authored papers 2
National Center for Advancing Translational Sciences
Co-authored papers 2
Foundation for the National Institutes of Health
Co-authored papers 2
University of Minnesota
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 1
Duke Clinical Research Institute, Duke University
Co-authored papers 1
University of Missouri-Kansas City School of Medicine
Co-authored papers 1
Focus Clinical Research Solutions
Co-authored papers 1
Medical University of South Carolina
Co-authored papers 1
Duke Clinical Research Institute, Duke University School of Medicine
Co-authored papers 1
University of Kansas Medical Center
Co-authored papers 1
NorthShore University HealthSystem
Co-authored papers 1
Stanford University
Co-authored papers 1
Co-authored papers 1
University of Missouri
Co-authored papers 1
Duke University
Co-authored papers 1